Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

The drug store says its the same…. But I’m worry to change concerning secondary effects.

March 19, 2025
 · 
Be the first to react
A MyBCTeam Member

Thats news to me Jeanne, I never heard of those kind before.

March 19, 2025
A MyBCTeam Member

Thank you very much!

March 19, 2025
MyBCTeam

Mint-Anastrozole and Apo-Anastrozole are both generic versions of anastrozole (brand name Arimidex). They contain the same active ingredient and work in the same way to treat hormone receptor-positive breast cancer. The pharmacy is correct - these medications are therapeutically equivalent.

Both versions will work to block Show Full Answer

Mint-Anastrozole and Apo-Anastrozole are both generic versions of anastrozole (brand name Arimidex). They contain the same active ingredient and work in the same way to treat hormone receptor-positive breast cancer. The pharmacy is correct - these medications are therapeutically equivalent.

Both versions will work to block estrogen production in the same way and should provide the same benefits in preventing breast cancer recurrence. The side effect profile would be the same since they contain identical active ingredients. If you notice any changes in how you feel after switching between versions, be sure to discuss this with your healthcare provider. They can monitor your response and address any concerns. Remember that you'll likely be taking this medication for several years, so it's important to feel confident in your treatment.

March 19, 2025

Related Questions

View All
A MyBCTeam Member asked a question 💭
Canada, KY

A MyBCTeam Subscriber asked a question 💭